Target intelligence / Profile preview

Adaptor related protein complex 2 subunit sigma 1 (AP2S1)

Target
AP2S1
Molecular classification
Vesicle coat protein, Adaptor protein complex subunit, Endocytosis-related protein, Other
01

Overview

Adaptor related protein complex 2 subunit sigma 1 (AP2S1) encodes the small sigma subunit of the AP-2 adaptor complex, a heterotetramer involved in clathrin-mediated endocytosis at the plasma membrane[1][4][6]. AP-2 is responsible for cargo selection and assembly of clathrin-coated vesicles, recognizing specific endocytic motifs in transmembrane cargo molecules[1][2][4][8]. AP2S1 is directly implicated in receptor-mediated endocytosis and the recycling of synaptic vesicle membranes, and may play a role in extracellular calcium homeostasis[2][8]. Mutations in AP2S1, particularly at residue Arg15, cause familial hypocalciuric hypercalcemia type 3, a genetic disorder disrupting calcium homeostasis due to impaired calcium-sensing receptor trafficking[2][8]. No drugs are currently known to directly target AP2S1; its fundamental cellular role suggests therapeutic targeting would present challenges related to disruption of essential trafficking mechanisms[2][4][8].

Other names
AP-2 complex subunit sigmaAP17CLAPS2FBH3FBHOkHHC3Sigma2-adaptinsigma-2Clathrin assembly protein 2 sigma small chainClathrin coat assembly protein AP17Clathrin coat-associated protein AP17Plasma membrane adaptor AP-2 17 kDa proteinHA2 17 kDa subunitClathrin-associated protein small 2
02

Mechanism of action

Not established for any current therapeutics; theoretical mechanisms may involve modulation of endocytosis or calcium-sensing receptor trafficking[2].

03

Biological functions

Clathrin-mediated endocytosisVesicle formationCargo selection and sortingSynaptic vesicle recyclingReceptor-mediated endocytosisMaintenance of extracellular calcium homeostasis
04

Disease associations

Familial hypocalciuric hypercalcemia type 3Possibly chondrocalcinosisOther
05

Safety considerations

Targeting AP2S1 could disrupt normal endocytosis, leading to widespread effects on cellular homeostasis and signaling
06

Biomarkers

Mutation status (e.g., R15 mutations) in AP2S1 is a biomarker for familial hypocalciuric hypercalcemia type 3[2][8].

Beyond the preview

Go deeper on Adaptor related protein complex 2 subunit sigma 1 (AP2S1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adaptor related protein complex 2 subunit sigma 1 (AP2S1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call